<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-36234" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Local Anesthetic Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahajan</surname>
            <given-names>Ajay</given-names>
          </name>
          <aff>Royal College of Surgeons in Ireland</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Derian</surname>
            <given-names>Armen</given-names>
          </name>
          <aff>Mayo Clinic</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ajay Mahajan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Armen Derian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-36234.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Local anesthetics are commonly used in most medical and dental practices. While adverse effects are rare, the rising prevalence of local anesthetics in practice has resulted in a greater incidence of local anesthetic toxicity. From minor symptoms to major cardiac or central nervous system effects, local anesthetic systemic toxicity (LAST) is an important consequence of which to be aware. Systemic toxicity was originally associated with seizures and respiratory failure. However, in the 1970s, cardiac effects were also recognized, as bupivacaine-associated fatal cardiac toxicity was discovered in healthy adults. This activity reviews the mechanisms, frequency, clinical characteristics, treatment, and prevention of local anesthetic toxicity</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess&#x000a0;the pathophysiology of local anesthetic toxicity.</p></list-item><list-item><p>Evaluate&#x000a0;the history and physical of a patient with local anesthetic toxicity.</p></list-item><list-item><p>Differentiate&#x000a0;the treatment and management options available for local anesthetic toxicity.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional team strategies for improving care and outcomes in patients with local anesthetic toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36234&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36234">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-36234.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Local anesthetics are commonly used in most medical and dental practices. While adverse effects are rare, the rising prevalence of local anesthetics in practice has resulted in a greater incidence of local anesthetic toxicity. From minor symptoms to major cardiac or central nervous system effects, local anesthetic systemic toxicity (LAST) is an important consequence of which to be aware. Systemic toxicity was originally associated with seizures and respiratory failure. However, in the 1970s, cardiac effects were also recognized, as bupivacaine-associated fatal cardiac toxicity was discovered in healthy adults. This&#x000a0;topic reviews the mechanisms, frequency, clinical characteristics, treatment, and prevention of LAST.<xref ref-type="bibr" rid="article-36234.r1">[1]</xref><xref ref-type="bibr" rid="article-36234.r2">[2]</xref><xref ref-type="bibr" rid="article-36234.r3">[3]</xref></p>
      </sec>
      <sec id="article-36234.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Accidental intravascular injection during the administration of local anesthetics has long been recognized as the most common cause of LAST.&#x000a0;However, certain&#x000a0;co-morbidities can also increase the risk of local anesthetic overdose and, in turn, systemic toxicity. These include hepatic dysfunction, cardiac disease, pregnancy, and metabolic syndromes. Additionally, patients at the extremes of age are at greater risk of toxicity due to reduced clearance of the anesthetics. Specifically, infants (younger than 4 months old) have low a-acid glycoprotein plasma concentrations, which can result in lower intrinsic clearance of bupivacaine.<xref ref-type="bibr" rid="article-36234.r4">[4]</xref><xref ref-type="bibr" rid="article-36234.r5">[5]</xref></p>
      </sec>
      <sec id="article-36234.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The reported incidence of LAST is highly variable. Some studies report 0 events after over 12,000 nerve blocks, whereas others report an incidence of up to 25 per 10,000 nerve blockades. One study reported seizures in 79 of 10,000 brachial plexus blockade procedures. This complication was due to LAST CNS toxicity as a result of the intravascular local anesthetic injection. Although the published data has been inconsistent,&#x000a0;1 common theme prevails: optimizing&#x000a0;the management of LAST is of the utmost importance&#x000a0;moving forward.<xref ref-type="bibr" rid="article-36234.r6">[6]</xref><xref ref-type="bibr" rid="article-36234.r7">[7]</xref></p>
      </sec>
      <sec id="article-36234.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>A mechanism for LAST has been difficult to establish, as its clinical presentation is highly variable. Additionally, the number of randomized clinical trials exploring specific mechanisms is limited. Most theories are based upon which binding site, ion channel, signaling pathway, or enzyme is involved in CNS and cardiac toxicity or their treatment.<xref ref-type="bibr" rid="article-36234.r8">[8]</xref><xref ref-type="bibr" rid="article-36234.r9">[9]</xref>&#x000a0;Local anesthetics inhibit many components of the oxidative phosphorylation pathway. Thus, LAST affects the 2 organs that are inherently less tolerant of anaerobic metabolism, the heart and brain.</p>
        <p>Cardiac toxicity&#x000a0;is an important component of LAST, and most instances are related to accidental intravascular injection. Local anesthetics bind to and inhibit voltage-gated sodium channels. Leading to conduction disturbances, contractile dysfunction, and ventricular arrhythmias that are seen in local anesthetic-induced cardiac toxicity. The incidence of cardiac toxicity increases with bupivacaine, a longer-acting anesthetic. Bupivacaine avidly blocks inactive sodium channels during the cardiac action potential at 0.2 micrograms/ml concentration.&#x000a0;This is done in a &#x0201c;fast-in/slow-out fashion,&#x0201d; meaning bupivacaine binds very&#x000a0;quickly to a large proportion of sodium channels during the cardiac action potential but releases from the channels slowly during diastole, resulting in a large proportion of the medication accumulating at 60 to 150 beats per&#x000a0;minute. Lidocaine at 5 to 10&#x000a0;micrograms/ml also results in substantial sodium channel blockade during a cardiac action potential. However, in contrast to bupivacaine, lidocaine follows the &#x0201c;fast-in/fast-out&#x0201d; principle, meaning it releases from sodium channels rapidly during diastole. This allows for a quicker recovery and a reduced incidence of cardiac toxicity when compared to bupivacaine.</p>
        <p>CNS toxicity is another important consequence of LAST. While it is comprised of many initial prodromal features, it most often manifests as seizures. One mechanistic theory is centered around Twik-related acid-sensitive K+ channels (TASK). These pH-sensitive channels generate neuronal potassium "leak" currents. Local anesthetic inhibition causes membrane depolarization and increased neuronal excitability. As these channels are expressed throughout the brain, this is the suggested mechanism for seizures in this setting.</p>
      </sec>
      <sec id="article-36234.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Early recognition of CNS and cardiac toxicity in LAST can drastically change the clinical course. Following a single local anesthetic injection, LAST presented within 50 seconds in 50% of cases studied and within 5 minutes in 75% of cases. If potentially toxic doses are administered, then it is recommended that patients be observed for at least 30 minutes.</p>
        <p>LAST most commonly presents with CNS changes. Initial signs and symptoms include agitation, confusion, dizziness, drowsiness, dysphoria, auditory changes, tinnitus, perioral numbness, metallic taste, and dysarthria. Without adequate recognition and treatment, these signs as symptoms can progress to seizures, respiratory arrest, and/or coma. While CNS toxicity often presents with the above initial features, the most common consequence is seizures. Additionally, in the setting of intravascular injection, seizures can be the initial presentation.</p>
        <p>Historically, local anesthetic literature suggested that cardiac toxicity is often presented after antecedent CNS toxicity. However, with more potent local anesthetics, cardiac toxicity has been found to arise concurrently with seizures or even precede them. Hypotension and bradycardia are often the first signs of cardiac toxicity. However, arrhythmias are responsible for most reported cases, with bradyarrhythmias being the most common. Additional signs of cardiac toxicity include hypertension, dyspnea, pain, wide complex, ST-segment changes, asystole, tachycardia, and ventricular ectopy/tachycardia/fibrillation.</p>
      </sec>
      <sec id="article-36234.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Often, no tests are needed as local anesthetic toxicity is a clinical diagnosis. Depending on the circumstances, a complete blood count, chemistry, and electrocardiogram may be considered.<xref ref-type="bibr" rid="article-36234.r10">[10]</xref></p>
      </sec>
      <sec id="article-36234.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Initial management of LAST should be focused on airway management, circulatory support, and reduction of systemic side effects. Immediate ventilation and oxygenation to prevent hypoxia and acidosis can facilitate resuscitation and reduce the likelihood of progression to seizures or cardiovascular collapse. If seizures do&#x000a0;occur, immediate administration of benzodiazepines is recommended to prevent injury and acidosis. Propofol or thiopental can be used if benzodiazepines are unavailable. However, these agents may worsen any associated hypotension or cardiac depression. If these medications are unable to control tonic-clonic seizure movements, small doses of succinylcholine should be intermittently administered to stop muscular activity and further acidosis.<xref ref-type="bibr" rid="article-36234.r6">[6]</xref><xref ref-type="bibr" rid="article-36234.r7">[7]</xref><xref ref-type="bibr" rid="article-36234.r11">[11]</xref></p>
        <p>Management of local anesthetic-induced cardiac arrest is focused on restoring cardiac output. This is done to re-establish tissue perfusion and, in turn,&#x000a0;prevent and treat any underlying acidosis. Standard ACLS guidelines are recommended in this situation, with a few adjustments. Small doses of epinephrine (less than 1 microgram/kg) are preferred. Vasopressin should be avoided, as it can result in pulmonary hemorrhage. Additionally, calcium-channel blockers and B-adrenergic-receptor blockers are not recommended. If ventricular arrhythmias do occur, amiodarone is the preferred pharmacotherapy, as local anesthetics and procainamide can exacerbate the existing toxicity.</p>
        <p>Recent case studies support the use of lipid emulsion therapy as soon as prolonged seizure activity or local anesthetic-induced arrhythmias are suspected. Theories suggest it improves cardiac conduction, contractility, and coronary perfusion by drawing the lipid-soluble local anesthetic out of the cardiac tissue. A bolus of 1.5 mL/kg of 20% lipid emulsion and a subsequent infusion of 0.25 ml/kg per minute should be given. The infusion should be continued for 10 minutes after hemodynamic stability is attained. An additional bolus and an infusion rate increase to 0.5 mL/kg per minute can be administered if stability is not achieved. The maximum recommended dose for initial administration is approximately 10 mL/kg for 30 minutes. If cardiac stability has not been achieved following the modified ACLS guidelines and subsequent lipid emulsion therapy, then cardiopulmonary bypass is recommended until the local anesthetic has cleared.</p>
      </sec>
      <sec id="article-36234.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for local anesthetic toxicity include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anxiety disorder</p>
          </list-item>
          <list-item>
            <p>Anaphylaxis</p>
          </list-item>
          <list-item>
            <p>Illicit drug toxicity</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36234.s10" sec-type="Complications">
        <title>Complications</title>
        <p>The complications that can manifest with local anesthetic toxicity are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Seizures</p>
          </list-item>
          <list-item>
            <p>Cardiac arrest</p>
          </list-item>
          <list-item>
            <p>Hypotension</p>
          </list-item>
          <list-item>
            <p>Arrhythmias</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36234.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Prevention of any adverse event is often called the most effective "treatment." However, it is important to recognize that no specific intervention can eliminate risk. Prevention in the setting of LAST revolves around preventing intravascular injection. Intravascular test dosing, specifically with epinephrine, is a reliable prevention method. In cases where the heart rate increases by 10 beats per minute or more or the systolic blood pressure rises by 15 mm Hg or more, 10 to 15 micrograms/ml of intravascular test dosing with epinephrine has a sensitivity of 80%. While this test is important, it is important to recognize certain patient characteristics that can render it unreliable. These factors include patients anesthetized with general or neuraxial anesthesia, sedated patients, the elderly, or patients taking beta-blockers.</p>
        <p>Ultrasound guidance is another method of preventing intravascular injection. However, there are no formal randomized controlled trials that either confirm or deny a reduction of the toxicity. Limiting anesthetic doses can also prevent LAST, as studies show that in most peripheral nerve blocks, patients are often given&#x000a0;too much anesthetic, resulting in an overdose. The total dose (the product of volume x concentration) should be the minimum anesthetic needed to produce the required effect. This strategy is especially useful in patients at a greater risk for LAST, such as those described above.</p>
      </sec>
      <sec id="article-36234.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Local anesthetic systemic toxicity is a serious consequence. Early recognition can drastically change its clinical course. Today, research is focused on lipid emulsion therapy for severe local anesthetic systemic toxicity and its prodromes. While developing new treatment plans can help limit associated morbidity and mortality, prevention continues to be one&#x000a0;of the most effective therapies for LAST.</p>
      </sec>
      <sec id="article-36234.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Local anesthetics are widely used in most healthcare facilities. These agents can be injected at the bedside for a minor procedure, in the operating room, or the emergency department. In almost all cases where local anesthetics are used, nurses are often present to monitor the patient. The nurse should monitor the vital signs and maintain verbal contact with the patient when the local anesthetic is injected. Once an adverse reaction occurs, the key is supportive care with close monitoring. In addition, the patient should be advised to wear a medical alert bracelet if the reaction is due to an allergy. However, if the patient develops a seizure, then the risk of a repeat event is unlikely.<xref ref-type="bibr" rid="article-36234.r12">[12]</xref><xref ref-type="bibr" rid="article-36234.r13">[13]</xref></p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>Patients who develop an adverse reaction or a seizure can be managed with supportive care, including oxygenation and hydration. Most patients recover without any sequelae. Without treatment, the patient is at risk for hypotension, cardiac arrest, and seizures. Data from the poison control centers reveals that in 2016, there were only&#x000a0;4 deaths from local anesthetics.<xref ref-type="bibr" rid="article-36234.r14">[14]</xref><xref ref-type="bibr" rid="article-36234.r15">[15]</xref></p>
      </sec>
      <sec id="article-36234.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36234&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36234">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/medications/local-anesthetic-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=36234">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/36234/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=36234">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-36234.s15">
        <title>References</title>
        <ref id="article-36234.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Zisquit</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nedeff</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <chapter-title>Interscalene Block</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>9</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">30137775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Boghdadly</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Local anesthetic systemic toxicity: current perspectives.</article-title>
            <source>Local Reg Anesth</source>
            <year>2018</year>
            <volume>11</volume>
            <fpage>35</fpage>
            <page-range>35-44</page-range>
            <pub-id pub-id-type="pmid">30122981</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walker</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Sathyamoorthy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Birstler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bosenberg</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Flack</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Krane</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Sethna</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Suresh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taenzer</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Polaner</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sunder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pankovich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sawardekar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Birmingham</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marcelino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ramarmurthi</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Szmuk</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ungar</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Lozano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boretsky</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Matuszczak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Dillow</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Power</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pineda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hutchins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Spisak</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>DelPizzo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yalamanchili</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Venable</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Chaudahari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ohkawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Usljebrka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bhalla</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vanzillotta</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Apiliogullari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Ando</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pestieau</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rosenbloom</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>T</given-names>
              </name>
              <collab>Pediatric Regional Anesthesia Network Investigators</collab>
            </person-group>
            <article-title>Complications in Pediatric Regional Anesthesia: An Analysis of More than 100,000 Blocks from the Pediatric Regional Anesthesia Network.</article-title>
            <source>Anesthesiology</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>129</volume>
            <issue>4</issue>
            <fpage>721</fpage>
            <page-range>721-732</page-range>
            <pub-id pub-id-type="pmid">30074928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bina</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hersh</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Hilario</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>True Allergy to Amide Local Anesthetics: A Review and Case Presentation.</article-title>
            <source>Anesth Prog</source>
            <year>2018</year>
            <season>Summer</season>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-123</page-range>
            <pub-id pub-id-type="pmid">29952645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aydin</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Unexpected local anesthesia toxicity during the ultrasonography-guided peripheral nerve block.</article-title>
            <source>J Clin Anesth</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>50</volume>
            <fpage>26</fpage>
            <pub-id pub-id-type="pmid">29945068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neal</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>The American Society of Regional Anesthesia and Pain Medicine Checklist for Managing Local Anesthetic Systemic Toxicity: 2017 Version.</article-title>
            <source>Reg Anesth Pain Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>150</fpage>
            <page-range>150-153</page-range>
            <pub-id pub-id-type="pmid">29356775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neal</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Barrington</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Fettiplace</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Gitman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Memtsoudis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>M&#x000f6;rwald</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The Third American Society of Regional Anesthesia and Pain Medicine Practice Advisory on Local Anesthetic Systemic Toxicity: Executive Summary 2017.</article-title>
            <source>Reg Anesth Pain Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-123</page-range>
            <pub-id pub-id-type="pmid">29356773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haskins</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Boublik</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Sloth</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Focused Cardiac Ultrasound for the Regional Anesthesiologist and Pain Specialist.</article-title>
            <source>Reg Anesth Pain Med</source>
            <year>2017</year>
            <season>Sep/Oct</season>
            <volume>42</volume>
            <issue>5</issue>
            <fpage>632</fpage>
            <page-range>632-644</page-range>
            <pub-id pub-id-type="pmid">28786898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bentov</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Damodarasamy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spiekerman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Lidocaine Impairs Proliferative and Biosynthetic Functions of Aged Human Dermal Fibroblasts.</article-title>
            <source>Anesth Analg</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>616</fpage>
            <page-range>616-23</page-range>
            <pub-id pub-id-type="pmid">27537755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liew</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lundblad</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Obley</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Local Anesthetic Systemic Toxicity Complicating Thyroid Biopsy.</article-title>
            <source>Cureus</source>
            <year>2017</year>
            <month>Dec</month>
            <day>16</day>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>e1955</fpage>
            <pub-id pub-id-type="pmid">29487769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sekimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tobe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Local anesthetic toxicity: acute and chronic management.</article-title>
            <source>Acute Med Surg</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-160</page-range>
            <pub-id pub-id-type="pmid">29123854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stearns</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Boortz-Marx</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Du Pen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Friehs</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Halyard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Herbst</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kiser</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.</article-title>
            <source>J Support Oncol</source>
            <year>2005</year>
            <season>Nov-Dec</season>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>399</fpage>
            <page-range>399-408</page-range>
            <pub-id pub-id-type="pmid">16350425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunter</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Mariano</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Care of the Patient With a Peripheral Nerve Block.</article-title>
            <source>J Perianesth Nurs</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-26</page-range>
            <pub-id pub-id-type="pmid">29678320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferguson</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Coogle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Leppert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Odom-Maryon</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Local Anesthetic Systemic Toxicity (LAST): Designing an Educational Effort for Nurses That Will Last.</article-title>
            <source>J Perianesth Nurs</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>180</fpage>
            <page-range>180-187</page-range>
            <pub-id pub-id-type="pmid">29934076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36234.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gitman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barrington</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Local Anesthetic Systemic Toxicity: A Review of Recent Case Reports and Registries.</article-title>
            <source>Reg Anesth Pain Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>124</fpage>
            <page-range>124-130</page-range>
            <pub-id pub-id-type="pmid">29303925</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
